Get started
Author

Orsola Crespi

Observed name: Orsola CRESPI
ORCID: 0009-0001-9270-1204
Observed ORCID: 0009-0001-9270-1204
OpenAlex ID: A5099034147
The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies
2025 · Valentina Pala, Francois Rosset, et al. · International Journal of Molecular Sciences · 24
PDF
Cosmeceuticals for Anti-Aging: Mechanisms, Clinical Evidence, and Regulatory Insights—A Comprehensive Review
2025 · Orsola Crespi, François Rosset, et al. · Cosmetics · 21
PDF
Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence
2025 · Francois Rosset, Nadia Sciamarrelli, et al. · Antibodies · 5
PDF
Pharmacomicrobiomics in Psoriasis: Microbiome–Drug Interactions Across Systemic Treatments
2026 · Umberto Santaniello, Luca Mastorino, et al. · Life · 3
PDF
Dupilumab Use in Severe Epidermolysis Bullosa Simplex
2026 · Orsola Crespi, Nathalia Bellon, et al. · JAMA Dermatology · 2
The Aging Skin–Psoriasis Interface: Could Cellular Senescence and Immunosenescence Slow Therapeutic Response?
2026 · Umberto Santaniello, François Rosset, et al. · Dermato · 1
PDF
Rituximab-induced nonuremic calciphylaxis in hairy cell leukemia: a singular case
2025 · Eleonora BONGIOVANNI, Orsola CRESPI, et al. · Italian Journal of Dermatology and Venereology · 1
Hypopigmented mycosis fungoides in pediatrics
2025 · Orsola CRESPI, Isotta GIUNIPERO DI CORTERANZO, et al. · Italian Journal of Dermatology and Venereology · 1
Mogamulizumab associated crusted scabies: a rare diagnostic confounder
2024 · Isotta GIUNIPERO DI CORTERANZO, Gabriele ROCCUZZO, et al. · Italian Journal of Dermatology and Venereology · 1
Real-World Outcomes After Switching from Baricitinib to Ritlecitinib in Alopecia Areata: A Multicentre Retrospective Cohort Study
2026 · Giuseppe Gallo, Isotta Giunipero di Corteranzo, et al. · American Journal of Clinical Dermatology
Real-World Strategies for Biologic Dose Escalation and Reduction in Psoriasis and Psoriatic Arthritis: A Systematic Review
2026 · Orsola Crespi, Isotta Giunipero di Corteranzo, et al. · Journal of Cutaneous Medicine and Surgery
PDF
Dissecting Cellulitis and Hidradenitis Suppurativa: Two Diseases or One Follicular‐Occlusion Spectrum?
2026 · Giuseppe Gallo, Federica Repetto, et al. · International Journal of Dermatology
PDF
Real-World Effectiveness of Secukinumab in Congenital Ichthyoses: A Retrospective Monocentric Case Series
2026 · Orsola Crespi, Umberto Santaniello, et al. · Antibodies
Dermatologic Perspectives on Primary Cutaneous Lymphomas: Clinicopathologic Spectrum, Molecular Insights, and Evolving Treatment Paradigms
2026 · Orsola Crespi, François Rosset, et al. · Lymphatics
PDF
Melanoma Clues Beyond Dermoscopic Patterns: Lesion Orientation to Langer’s Lines as a Predictor on the Trunk
2025 · Umberto Santaniello, Francesco Cavallo, et al. · Cancers
“Full-naïve” patients: the impact of previous methotrexate, cyclosporine, and acitretin on first-line biologics response in the treatment of moderate-to-severe psoriasis – a monocentric retrospective study
2025 · Luca Mastorino, Paolo Dapavo, et al. · Expert Opinion on Biological Therapy
Clinic, dermoscopy and histology of Merkel cell carcinoma in a patient with a prior nodular melanoma on the ipsilateral limb
2025 · Silvia BORRIELLO, Umberto SANTANIELLO, et al. · Italian Journal of Dermatology and Venereology
Acneiform rash associated with amivantamab, a novel anti-EGFR treatment for NSCLC
2024 · Orsola CRESPI, Valentina CELORIA, et al. · Italian Journal of Dermatology and Venereology
Works count: 18
Citation count: 59
H-index: 3
I10-index: 2
Year
Topic
Type